President Biden Signs Legislation Boosting Generic and Biosimilar Drugs to Help Foster Price Competition

Published date04 May 2021
Subject MatterAmerican Rescue Plan Act of 2021,Biosimilars,Prescription Drugs,Biden Administration,Pharmaceutical Industry,Innovation,FDA,Life Sciences,Generic Drugs,BPCIA
AuthorMichael Gallagher,Kevin Adam
Law FirmWhite & Case LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT